A systematic review and meta‑analysis of Arbidol therapy for acute respiratory viral infections: A potential treatment for COVID‑19

Arbidol (ARB) is efficacious for the treatment of influenza, and has been recommended for COVID-19. The present systematic review was performed to assess the existing knowledge on ARB therapy for acute respiratory viral infections, especially COVID-19. Subsequently, six databases were searched for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ting, Zhang, Xin, Sun, Yin, Yang, Jingyu, Du, Hengjian, Guo, Jianshu, Tang, Rongzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716115/
https://www.ncbi.nlm.nih.gov/pubmed/36478885
http://dx.doi.org/10.3892/etm.2022.11672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716115/
https://www.ncbi.nlm.nih.gov/pubmed/36478885
http://dx.doi.org/10.3892/etm.2022.11672

Ejemplares similares